Effect of diuretics and sodium-restricted diet on sleep apnea severity : study protocol for a randomized controlled trial
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFRGS |
Texto Completo: | http://hdl.handle.net/10183/117961 |
Resumo: | Background: Obstructive sleep apnea occurs as a result of increased collapsibility of the upper airway. Overnight fluid displacement from the legs to the neck causes pharyngeal narrowing and increased apnea severity. Sodium intake is associated with apnea severity. We hypothesized that interventions that decrease bodily fluid content might reduce the severity of sleep apnea. Methods/design: This is a randomized clinical trial including men with an apnea-hypopnea index greater than 30 events/hour, previously diagnosed by full-night in-laboratory polysomnography. A total of 54 men will be included and randomly assigned to three groups: Diuretic (n = 18), sodium-restricted diet (n = 18), and control (n = 18). The intervention will last one week. Intention-to-treat and per-protocol analyses will be performed. The diuretic group will receive combined spironolactone 100 mg plus furosemide 20 mg daily, taken in the morning. The diet group will receive a regimen with a maximum intake of 3 g of sodium per day. The control group will receive a placebo pill and will maintain all eating habits while keeping a recall diary of their dietary behavior. The primary outcome measure will be change in apnea-hypopnea index. The secondary outcome measures will be variations of: anthropometric and bioelectrical impedance variables, office blood pressure, respiratory variables from in-home level III polysomnography, excessive daytime sleepiness, glycolipid profile, C-reactive protein, 24 h urinary variables, and adverse events. Discussion: Despite the high efficacy of continuous positive airway pressure to reverse upper airway obstruction in sleep apnea, partial adherence to this form of treatment reduces its efficiency. Thus, additional forms of treating apnea need to be investigated. If the results of this proof-of-concept trial show that decreases in bodily fluid content, either by diuretic or dietary intervention, reduces the severity of sleep apnea, further investigation will be necessary before these results can be translated and adopted as an adjunct apnea therapy. |
id |
UFRGS-2_2a63220a7039a9aa21f4dc4b5ab63d7a |
---|---|
oai_identifier_str |
oai:www.lume.ufrgs.br:10183/117961 |
network_acronym_str |
UFRGS-2 |
network_name_str |
Repositório Institucional da UFRGS |
repository_id_str |
|
spelling |
Fiori, Cintia ZappeMartinez, DenisGonçalves, Sandro CadavalMontanari, Carolina CaruccioFuchs, Flávio Danni2015-06-19T02:00:27Z20141745-6215http://hdl.handle.net/10183/117961000967847Background: Obstructive sleep apnea occurs as a result of increased collapsibility of the upper airway. Overnight fluid displacement from the legs to the neck causes pharyngeal narrowing and increased apnea severity. Sodium intake is associated with apnea severity. We hypothesized that interventions that decrease bodily fluid content might reduce the severity of sleep apnea. Methods/design: This is a randomized clinical trial including men with an apnea-hypopnea index greater than 30 events/hour, previously diagnosed by full-night in-laboratory polysomnography. A total of 54 men will be included and randomly assigned to three groups: Diuretic (n = 18), sodium-restricted diet (n = 18), and control (n = 18). The intervention will last one week. Intention-to-treat and per-protocol analyses will be performed. The diuretic group will receive combined spironolactone 100 mg plus furosemide 20 mg daily, taken in the morning. The diet group will receive a regimen with a maximum intake of 3 g of sodium per day. The control group will receive a placebo pill and will maintain all eating habits while keeping a recall diary of their dietary behavior. The primary outcome measure will be change in apnea-hypopnea index. The secondary outcome measures will be variations of: anthropometric and bioelectrical impedance variables, office blood pressure, respiratory variables from in-home level III polysomnography, excessive daytime sleepiness, glycolipid profile, C-reactive protein, 24 h urinary variables, and adverse events. Discussion: Despite the high efficacy of continuous positive airway pressure to reverse upper airway obstruction in sleep apnea, partial adherence to this form of treatment reduces its efficiency. Thus, additional forms of treating apnea need to be investigated. If the results of this proof-of-concept trial show that decreases in bodily fluid content, either by diuretic or dietary intervention, reduces the severity of sleep apnea, further investigation will be necessary before these results can be translated and adopted as an adjunct apnea therapy.application/pdfengTrials. [London]. Vol. 16, no. 1 (Apr. 2015), p. 188,Apneia obstrutiva do sonoDiuréticosFurosemidaBody fluidsDiureticFurosemideSleep apneaSodium-restricted dietSpironolactoneTreatmentEffect of diuretics and sodium-restricted diet on sleep apnea severity : study protocol for a randomized controlled trialEstrangeiroinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSORIGINAL000967847.pdf000967847.pdfTexto completo (inglês)application/pdf1341625http://www.lume.ufrgs.br/bitstream/10183/117961/1/000967847.pdfdb9cc09cd7830a7f386203c2dba6bfe3MD51TEXT000967847.pdf.txt000967847.pdf.txtExtracted Texttext/plain27620http://www.lume.ufrgs.br/bitstream/10183/117961/2/000967847.pdf.txt11e1fdab4ed27df8486eff8f2d806549MD52THUMBNAIL000967847.pdf.jpg000967847.pdf.jpgGenerated Thumbnailimage/jpeg1928http://www.lume.ufrgs.br/bitstream/10183/117961/3/000967847.pdf.jpg57937dba0d1f509ea8a3d3cf78a7ab40MD5310183/1179612018-10-18 09:20:21.193oai:www.lume.ufrgs.br:10183/117961Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2018-10-18T12:20:21Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.pt_BR.fl_str_mv |
Effect of diuretics and sodium-restricted diet on sleep apnea severity : study protocol for a randomized controlled trial |
title |
Effect of diuretics and sodium-restricted diet on sleep apnea severity : study protocol for a randomized controlled trial |
spellingShingle |
Effect of diuretics and sodium-restricted diet on sleep apnea severity : study protocol for a randomized controlled trial Fiori, Cintia Zappe Apneia obstrutiva do sono Diuréticos Furosemida Body fluids Diuretic Furosemide Sleep apnea Sodium-restricted diet Spironolactone Treatment |
title_short |
Effect of diuretics and sodium-restricted diet on sleep apnea severity : study protocol for a randomized controlled trial |
title_full |
Effect of diuretics and sodium-restricted diet on sleep apnea severity : study protocol for a randomized controlled trial |
title_fullStr |
Effect of diuretics and sodium-restricted diet on sleep apnea severity : study protocol for a randomized controlled trial |
title_full_unstemmed |
Effect of diuretics and sodium-restricted diet on sleep apnea severity : study protocol for a randomized controlled trial |
title_sort |
Effect of diuretics and sodium-restricted diet on sleep apnea severity : study protocol for a randomized controlled trial |
author |
Fiori, Cintia Zappe |
author_facet |
Fiori, Cintia Zappe Martinez, Denis Gonçalves, Sandro Cadaval Montanari, Carolina Caruccio Fuchs, Flávio Danni |
author_role |
author |
author2 |
Martinez, Denis Gonçalves, Sandro Cadaval Montanari, Carolina Caruccio Fuchs, Flávio Danni |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Fiori, Cintia Zappe Martinez, Denis Gonçalves, Sandro Cadaval Montanari, Carolina Caruccio Fuchs, Flávio Danni |
dc.subject.por.fl_str_mv |
Apneia obstrutiva do sono Diuréticos Furosemida |
topic |
Apneia obstrutiva do sono Diuréticos Furosemida Body fluids Diuretic Furosemide Sleep apnea Sodium-restricted diet Spironolactone Treatment |
dc.subject.eng.fl_str_mv |
Body fluids Diuretic Furosemide Sleep apnea Sodium-restricted diet Spironolactone Treatment |
description |
Background: Obstructive sleep apnea occurs as a result of increased collapsibility of the upper airway. Overnight fluid displacement from the legs to the neck causes pharyngeal narrowing and increased apnea severity. Sodium intake is associated with apnea severity. We hypothesized that interventions that decrease bodily fluid content might reduce the severity of sleep apnea. Methods/design: This is a randomized clinical trial including men with an apnea-hypopnea index greater than 30 events/hour, previously diagnosed by full-night in-laboratory polysomnography. A total of 54 men will be included and randomly assigned to three groups: Diuretic (n = 18), sodium-restricted diet (n = 18), and control (n = 18). The intervention will last one week. Intention-to-treat and per-protocol analyses will be performed. The diuretic group will receive combined spironolactone 100 mg plus furosemide 20 mg daily, taken in the morning. The diet group will receive a regimen with a maximum intake of 3 g of sodium per day. The control group will receive a placebo pill and will maintain all eating habits while keeping a recall diary of their dietary behavior. The primary outcome measure will be change in apnea-hypopnea index. The secondary outcome measures will be variations of: anthropometric and bioelectrical impedance variables, office blood pressure, respiratory variables from in-home level III polysomnography, excessive daytime sleepiness, glycolipid profile, C-reactive protein, 24 h urinary variables, and adverse events. Discussion: Despite the high efficacy of continuous positive airway pressure to reverse upper airway obstruction in sleep apnea, partial adherence to this form of treatment reduces its efficiency. Thus, additional forms of treating apnea need to be investigated. If the results of this proof-of-concept trial show that decreases in bodily fluid content, either by diuretic or dietary intervention, reduces the severity of sleep apnea, further investigation will be necessary before these results can be translated and adopted as an adjunct apnea therapy. |
publishDate |
2014 |
dc.date.issued.fl_str_mv |
2014 |
dc.date.accessioned.fl_str_mv |
2015-06-19T02:00:27Z |
dc.type.driver.fl_str_mv |
Estrangeiro info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10183/117961 |
dc.identifier.issn.pt_BR.fl_str_mv |
1745-6215 |
dc.identifier.nrb.pt_BR.fl_str_mv |
000967847 |
identifier_str_mv |
1745-6215 000967847 |
url |
http://hdl.handle.net/10183/117961 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.pt_BR.fl_str_mv |
Trials. [London]. Vol. 16, no. 1 (Apr. 2015), p. 188, |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFRGS instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Repositório Institucional da UFRGS |
collection |
Repositório Institucional da UFRGS |
bitstream.url.fl_str_mv |
http://www.lume.ufrgs.br/bitstream/10183/117961/1/000967847.pdf http://www.lume.ufrgs.br/bitstream/10183/117961/2/000967847.pdf.txt http://www.lume.ufrgs.br/bitstream/10183/117961/3/000967847.pdf.jpg |
bitstream.checksum.fl_str_mv |
db9cc09cd7830a7f386203c2dba6bfe3 11e1fdab4ed27df8486eff8f2d806549 57937dba0d1f509ea8a3d3cf78a7ab40 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
|
_version_ |
1801224873062694912 |